Buscar
QuidelOrtho Corp
QDELAñadir a la lista de seguimiento
16.770USD
+0.200+1.21%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
1.14BCap. mercado
PérdidaP/E TTM
Más Datos de QuidelOrtho Corp Compañía
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Información de QuidelOrtho Corp
Símbolo de cotizaciónQDEL
Nombre de la empresaQuidelOrtho Corp
Fecha de salida a bolsaFeb 01, 1991
Director ejecutivoBlaser (Brian J)
Número de empleados6600
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 01
Dirección9975 Summers Ridge Road
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Teléfono18585521100
Sitio Webhttps://www.quidelortho.com/
Símbolo de cotizaciónQDEL
Fecha de salida a bolsaFeb 01, 1991
Director ejecutivoBlaser (Brian J)
Ejecutivos de QuidelOrtho Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
23.26K
+35.41%
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
9.35K
+73.02%
Dr. Mary Lake Polan, M.D., Ph.D.
Dr. Mary Lake Polan, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Kenneth Jon (Ken) Widder, M.D.
Dr. Kenneth Jon (Ken) Widder, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de QuidelOrtho Corp?
Los cinco principales accionistas de QuidelOrtho Corp son: Dr. Kenneth F. Buechler, Ph.D.
¿Cuántas instituciones poseen acciones de QuidelOrtho Corp (QDEL)?
A fecha de 2026Q1, 619 instituciones poseen acciones de QuidelOrtho Corp, con un valor de mercado combinado de aproximadamente 88.33M, lo que representa el 129.53% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -14180850.00.
¿Cuál es la mayor fuente de ganancias de QuidelOrtho Corp?
El 2026Q1, el segmento empresarial Labs generó la ganancia más alta para QuidelOrtho Corp, ascendiendo a 373.80M y representando el 53.41% de la ganancia total.